Skip to content

To evaluate the efficacy and safety of endoscopic surgical system assisted laparoscopic staging of endometrial cancer in clinical trials

To evaluate the efficacy and safety of endoscopic surgical system assisted laparoscopic staging of endometrial cancer in clinical trials

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200063173
Enrollment
Unknown
Registered
2022-09-01
Start date
2022-09-01
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endometrial cancer

Interventions

Sponsors

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with endometrial cancer with lesions confined to the uterus; 2. The pathology of curettage was endometrioid carcinoma; 3. Women aged 18-80 years; 4. Able to cooperate with and complete follow-up and relevant examinations; 5. Voluntarily participate in this experiment and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. There is a serious uncontrolled disease or acute infection; 2. Patients with cardiovascular and cerebrovascular diseases, blood system diseases, immune system diseases and diabetes that cannot be controlled and cannot meet surgical standards; 3. Scrape pathology suggested high-grade (G3), serous carcinoma, clear cell carcinoma, carcinosarcoma; 4. Preoperative MRI indicated deep muscle infiltration; 5. Imaging showed positive pelvic lymph nodes (MRI or CT showed short diameter >=1.5cm, or SUV>=2.5); 6. Poor vaginal condition, unable to complete removal of the uterus (assessed by the researcher); 7. Patients with severe pelvic and abdominal adhesion, unsuitable for laparoscopic surgery; 8. Participating in other investigational drug or device clinical trials that have not been completed.

Design outcomes

Primary

MeasureTime frame
Successful operation;

Secondary

MeasureTime frame
Number of lymph nodes removed;Surgeon satisfaction;

Countries

China

Contacts

Public ContactXiang Yang
Xiangy@pumch.cn+86 13511050222

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026